These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34578271)

  • 21. The K46 and K5 capsular polysaccharides produced by Acinetobacter baumannii NIPH 329 and SDF have related structures and the side-chain non-ulosonic acids are 4-O-acetylated by phage-encoded O-acetyltransferases.
    Kenyon JJ; Arbatsky NP; Shneider MM; Popova AV; Dmitrenok AS; Kasimova AA; Shashkov AS; Hall RM; Knirel YA
    PLoS One; 2019; 14(6):e0218461. PubMed ID: 31220143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and therapeutic potential of MRABP9, a novel lytic bacteriophage infecting multidrug-resistant Acinetobacter baumannii clinical strains.
    Zhang Y; Shao Y; You H; Shen Y; Miao F; Yuan C; Chen X; Zhai M; Shen Y; Zhang J
    Virology; 2024 Jul; 595():110098. PubMed ID: 38705084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2.
    Lee CN; Tseng TT; Lin JW; Fu YC; Weng SF; Tseng YH
    Appl Environ Microbiol; 2011 Oct; 77(19):6755-62. PubMed ID: 21821767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Tail Associated Protein of Acinetobacter baumannii Phage ΦAB6 Is the Host Specificity Determinant Possessing Exopolysaccharide Depolymerase Activity.
    Lai MJ; Chang KC; Huang SW; Luo CH; Chiou PY; Wu CC; Lin NT
    PLoS One; 2016; 11(4):e0153361. PubMed ID: 27077375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of a Phage-Encoded Wzy Protein in the Polymerization of K127 Units To Form the Capsular Polysaccharide of Acinetobacter baumannii Isolate 36-1454.
    Arbatsky NP; Kasimova AA; Shashkov AS; Shneider MM; Popova AV; Shagin DA; Shelenkov AA; Mikhailova YV; Yanushevich YG; Hall RM; Knirel YA; Kenyon JJ
    Microbiol Spectr; 2022 Jun; 10(3):e0150321. PubMed ID: 35475638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific Interaction of Novel
    Popova AV; Shneider MM; Arbatsky NP; Kasimova AA; Senchenkova SN; Shashkov AS; Dmitrenok AS; Chizhov AO; Mikhailova YV; Shagin DA; Sokolova OS; Timoshina OY; Kozlov RS; Miroshnikov KA; Knirel YA
    J Virol; 2021 Mar; 95(5):. PubMed ID: 33268523
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization and efficacy against carbapenem-resistant
    Wang Z; Yang X; Wang H; Wang S; Fang R; Li X; Xing J; Wu Q; Li Z; Song N
    Front Cell Infect Microbiol; 2024; 14():1382145. PubMed ID: 38736748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotics Act with vB_AbaP_AGC01 Phage against
    Grygorcewicz B; Roszak M; Golec P; Śleboda-Taront D; Łubowska N; Górska M; Jursa-Kulesza J; Rakoczy R; Wojciuk B; Dołęgowska B
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.
    Jeon J; Ryu CM; Lee JY; Park JH; Yong D; Lee K
    Appl Environ Microbiol; 2016 Jul; 82(14):4200-4208. PubMed ID: 27208124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and genome annotation of a newly detected bacteriophage infecting multidrug-resistant Acinetobacter baumannii.
    Yang Z; Liu X; Shi Y; Yin S; Shen W; Chen J; Chen Y; Chen Y; You B; Gong Y; Luo X; Zhang C; Yuan Z; Peng Y
    Arch Virol; 2019 Jun; 164(6):1527-1533. PubMed ID: 30900072
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Timoshina OY; Kasimova AA; Shneider MM; Matyuta IO; Nikolaeva AY; Evseev PV; Arbatsky NP; Shashkov AS; Chizhov AO; Shelenkov AA; Mikhaylova YV; Slukin PV; Volozhantsev NV; Boyko KM; Knirel YA; Miroshnikov KA; Popova AV
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240444
    [No Abstract]   [Full Text] [Related]  

  • 32. Resistance to bacteriophage incurs a cost to virulence in drug-resistant
    Manley R; Fitch C; Francis V; Temperton I; Turner D; Fletcher J; Phil M; Michell S; Temperton B
    J Med Microbiol; 2024 May; 73(5):. PubMed ID: 38743467
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization and complete genome sequence analysis of two Myoviral bacteriophages infecting clinical carbapenem-resistant Acinetobacter baumannii isolates.
    Jeon J; D'Souza R; Pinto N; Ryu CM; Park J; Yong D; Lee K
    J Appl Microbiol; 2016 Jul; 121(1):68-77. PubMed ID: 26991925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii.
    Yuan Y; Wang L; Li X; Tan D; Cong C; Xu Y
    Virus Res; 2019 Oct; 272():197734. PubMed ID: 31465789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host.
    Blasco L; Bleriot I; González de Aledo M; Fernández-García L; Pacios O; Oliveira H; López M; Ortiz-Cartagena C; Fernández-Cuenca F; Pascual Á; Martínez-Martínez L; Pachón J; Azeredo J; Tomás M
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0192321. PubMed ID: 35041503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative genome analysis of novel Podoviruses lytic for hypermucoviscous Klebsiella pneumoniae of K1, K2, and K57 capsular types.
    Solovieva EV; Myakinina VP; Kislichkina AA; Krasilnikova VM; Verevkin VV; Mochalov VV; Lev AI; Fursova NK; Volozhantsev NV
    Virus Res; 2018 Jan; 243():10-18. PubMed ID: 28988127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage.
    Sisakhtpour B; Mirzaei A; Karbasizadeh V; Hosseini N; Shabani M; Moghim S
    Ann Clin Microbiol Antimicrob; 2022 Jan; 21(1):1. PubMed ID: 34996464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).
    Huang G; Shen X; Gong Y; Dong Z; Zhao X; Shen W; Wang J; Hu F; Peng Y
    BMC Infect Dis; 2014 Dec; 14():681. PubMed ID: 25495514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatic analysis of the Acinetobacter baumannii phage AB1 genome.
    Li P; Chen B; Song Z; Song Y; Yang Y; Ma P; Wang H; Ying J; Ren P; Yang L; Gao G; Jin S; Bao Q; Yang H
    Gene; 2012 Oct; 507(2):125-34. PubMed ID: 22868206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Fri1-like Viruses Infecting Acinetobacter baumannii-vB_AbaP_AS11 and vB_AbaP_AS12-Characterization, Comparative Genomic Analysis, and Host-Recognition Strategy.
    Popova AV; Lavysh DG; Klimuk EI; Edelstein MV; Bogun AG; Shneider MM; Goncharov AE; Leonov SV; Severinov KV
    Viruses; 2017 Jul; 9(7):. PubMed ID: 28714913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.